Atlas
Pharmacology diagrams
42 cases to look at, with the source of every image. The guided reading of each one is in the app.

ADME (absorption-distribution-metabolism-excretion)

Half-life and elimination

Agonist, partial agonist and antagonist

Drug-receptor binding

G protein-coupled receptor

cAMP pathway (second messenger)

Nuclear receptor (steroid)

Sympathetic system

Parasympathetic system

GABA-A receptor

Dopaminergic pathways

Opioid receptors

Cardiac glycosides (digoxin)

Targets of antibiotics

Protein synthesis inhibitors

Antibiotic resistance mechanisms

NSAIDs (COX inhibition)

Paracetamol Toxicity (NAPQI)

Drug metabolism (phases I and II)

Bioavailability

Structured recognition · ADME (absorption-distribution-metabolism-excretion)

Key findings · Sympathetic system

Key findings · Parasympathetic system

Structured recognition · GABA-A receptor

Structured recognition · The GABAergic synapse as a therapeutic target

Key findings · Dopaminergic pathways

Key findings · Opioid receptors

Structured recognition · Protein synthesis inhibitors

Structured recognition · NSAIDs (COX inhibition)

Dose-response curve and drug types

Elimination kinetics: order 0 vs order 1

Therapeutic window and therapeutic index

Concentration-time curve (single oral dose)

First order elimination on semilogarithmic scale

Bioavailability: intravenous vs oral route

Quantum dose-response curve (ED50, TD50, LD50)

Competitive vs non-competitive antagonism

Steady state accumulation (multiple doses)

Insulin: time-action profiles

Essential adrenergic receptors

Anticholinergic toxidrome

The GABAergic synapse as a therapeutic target
No cases match those filters.